Alfuzosin 10 mg once daily for treating benign prostatic hyperplasia: A 3-year experience in real-life practice

Guy Vallancien*, Mark Emberton, Antonio Alcaraz, Haim Matzkin, R. Jeroen A. Van Moorselaar, Rudolf Hartung, Niels Harving, Mostafa Elhilali

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

53 Scopus citations

Fingerprint

Dive into the research topics of 'Alfuzosin 10 mg once daily for treating benign prostatic hyperplasia: A 3-year experience in real-life practice'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Agricultural and Biological Sciences